Siemens Healthineers gets FDA clearance for 6 Artis interventional systems

Siemens Healthineers has received FDA clearance for 6 new systems in its Artis interventional imaging portfolio, according to the company.

The cleared portfolio includes the floor, biplane, ceiling, and pheno versions of the Artis vision platform, as well as floor configurations of the Artis icono.explore and Artis genio platforms.

Each system includes the company’s Optiq AI imaging chain, which uses AI to analyze and optimize image data in real time.

Optiq AI applies deep-learning-based noise reduction across 2D imaging modes, including fluoroscopy, acquisition, and digital subtraction angiography. Siemens Healthineers said the denoising is intended to provide consistent visualization during interventional procedures.

Kris McVey, head of angiography in the Advanced Therapies business at Siemens Healthineers North America, said “increased precision is of paramount importance” as more complex procedures move into interventional labs.

Advanced 3D applications in the portfolio include syngo DynaCT MORE, which is designed to reduce motion-related artifacts during intraprocedural 3D imaging. The portfolio also includes Touch UI tableside controls and standardized controls across systems.

The Artis vision systems are designed for high-speed, precise image-guided procedures. Artis icono.explore floor is intended for high-throughput departments, while Artis genio floor is positioned for broad interventional case mixes, according to Siemens Healthineers.

Optiq AI was introduced in late 2025 during RSNA in Chicago.